PhRMA urges USTR to address Japan's 'damaging' pricing policy, commends China's progress

PhRMA said the Office of the United States Trade Representative must prioritize action to end Japan's "damaging" pricing regulations. In its submission for USTR's upcoming annual Special 301 Report, PhRMA said USTR should add Japan to its list of "Priority Foreign Countries," a designation PhRMA said is reserved "for

Read the full 490 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE